The following is a summary of “Discrepancies in Beta-Lactam Antibiotics Cross-Reactivity: Implications for Clinical Practice,” published in the February 2025 issue of European Journal of Allergy and ...
Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat ...
Relebactam has been designed to inhibit a key resistance mechanism that limits the effectiveness of beta lactam antibiotics, including carbapenems like imipenem that have become last-line ...
A study of 151 patients with carbapenem-nonsusceptible infections found treatment with imipenem/cilastatin/relebactam was ...
Yesterday during President Donald Trump's first cabinet meeting, Health and Human Services (HHS) Secretary Robert F. Kennedy ...
Sunday Trust on MSN4d
A stellar year for Nigeria's health sectorGovernment must redeem pledge on universal health coverage'. We appreciate the expressed views, but we wish to respectfully lay out the verifiable facts concerning government action in the health ...
Researchers have discovered a novel approach to protecting insulin-producing beta cells from the damaging effects of glucolipotoxicity - a harmful condition linked to the progression of type 2 ...
The best evidence demonstrates that around 0.21% of general paediatric outpatients demonstrate positive antibiotic intradermal (ID) testing or DPTs, while 6.8% of children attending emergency ...
Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback